In September, Petrovax Pharm once again proved the high quality of its vaccines and pharmaceuticals and their compliance with Good Manufacturing Practices (GMP). The State Institute for Drug Control (SUKL), Slovakia, inspected the company’s quality management system to extend its EU GMP compliance certificate. In addition, Petrovax Pharm received a GMP certificate from the Food and Drug Organisation of the Iranian Ministry of Health and Medical Education to become the first Russian biotech and pharmaceutical company to obtain a certificate from the Iranian government.
These certificates come as a result of Petrovax Pharm's continued commitment to GMP compliance. Back in 2012, Petrovax Pharm was one of the first Russian pharmaceutical companies to be EU GMP certified by the Ukrainian government. Within the same year, it was also awarded an EU GMP certificate from Slovakia.
As an official testimony to the high performance of Petrovax Pharm's production and quality management systems, certification by Slovak and Iranian regulators will help foster our international cooperation, expand coverage and gain foothold in the global market.
Viktor Nesterov, Quality Control Director, NPO Petrovax Pharm, commented on this development: “Since its inception, our company has been strongly committed to maintaining a quality control and assurance system to secure full compliance of our medicines with national and global standards. GMP certificates confirm our manufacturing and quality management excellence brought about by our team’s expertise and many years of hard work.”